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Background: Microbiological characteristics of sepsis and antimicrobial resistance are well studied, although in
State University of Campinas, no data has been published yet.
Methods: The main agents related to sepsis and antimicrobial resistance were analyzed. The blood culture records
requested from 4,793 hospitalized patients were analyzed. The samples were processed using the Bact/Alert®
system for agent identification and antimicrobial susceptibility.
Results: A total of 1,017 patients met the inclusion criteria for a sepsis diagnosis, with 2,309 samples tested
(2.27 samples/patient). There were 489 positive samples (21% positive) isolated from 337 patients (33.13%), but
more rigorous criteria excluding potential contaminants resulted in analysis being restricted to 266 patients
(315 agents). The prevalent microorganisms were coagulase negative Staphylococcus (CNS) (15.87%), Escherichia coli
(13.0%), Staphylococcus aureus (11.7%), Klebsiella pneumoniae (9.8%), Enterobacter sp (9.5%), Acinetobacter baumannii
(9.2%), Pseudomonas aeruginosa (5.7%) and Candida sp (5.1%). Examining antimicrobial resistance in the agents
revealed that 51% of the S. aureus isolates were methicillin-resistant S. aureus (MRSA) and 80% of the CNS isolates
were oxacillin-resistant. For A. baumannii, the ideal profile drugs were ampicillin sulbactam and piperacillin/tazobactam,
and for P. aeruginosa, they were piperacillin/tazobactam and ceftazidime. Enterobacteria showed on average 32.5% and
35.7% resistance to beta-lactams and ciprofloxacin, respectively. When all Gram-negative bacteria were considered, the
resistance to beta-lactams rose to 40.5%, and the resistance to ciprofloxacin rose to 42.3%.
Conclusions: Eighty percent of the agents identified in blood cultures from patients with sepsis belonged to a group
of eight different agents. For empirical treatment, carbapenems and vancomycin unfortunately still remain the best
therapeutic choice, except for A. baumannii and P. aeruginosa, for which piperacillin/tazobactan is the best option.
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Sepsis is one of the most serious and urgent infectious
events in clinical practice, and its diagnosis is traditio-
nally based on blood culture, defined as the presence
(probable or documented) of infection together with
systemic manifestations of infection [1]. Efforts for the
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unless otherwise stated.sensitivity CRP, PCT) as a molecular method for detec-
tion as well as identifying etiologic agents and resistance
markers are important approaches for the diagnosis of
this syndrome [2-12]. A simple bacteremia, which may
originate from the digestive tract and progress to a state
of septic shock and multiple organ dysfunction, involves
important variables, such as the agent involved, quantity
and virulence, type of invasion (continued or intermit-
tent), available diagnostic resources, host response to
infection and the precocity and adequacy of clinical-
therapeutic interventions. These are some of the deter-
mining factors influencing clinical outcome [9]. Therefore,ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tance and is one of the most frequently ordered tests in
the clinical microbiology laboratory [10]. Similarly, micro-
scopic examination following Gram staining on positive
blood cultures can quickly guide the clinician in choosing
an empirical antimicrobial therapy [13]. Recently, other la-
boratory approaches involving molecular techniques have
been incorporated, but these procedures remain limited
and costly [9,10,13,14]. These molecular techniques may
have a significant impact by increasing the early diagnosis
and detection of etiologic mechanisms of resistance. Some
important factors in the detection of blood cultures in-
clude the number of samples, volume, collection site, use
of automated systems for monitoring and type of incuba-
tion atmosphere (anaerobic or not). Other factors may
interfere to give false positive or negative results, such as
the use of antibiotics and antisepsis failures, and labora-
tory limitations may delay diagnosis or give incorrect in-
formation [15-18].
There are few data on the annual incidence of blood-
stream infections in the world, but sepsis is a leading
cause of death in hospitalized patients. In the U.S., ap-
proximately 750,000 cases of bloodstream infections
occur each year, resulting in 215,000 deaths [9,14]. In
Brazil, the current data show an incidence density of
sepsis from 57.9 per 1,000 patient-days, and the mortal-
ity rate of patients with systemic inflammatory response
syndrome (SIRS), sepsis, severe sepsis and septic shock
was 24.2%, 33.9%, 46.9% and 52.2%, respectively [19].
Brazilian and international studies generally emphasize
the clinical, epidemiological and diagnostic resources,
with limited analyses of both the agents involved and
the antimicrobial resistance of the agents; such analyses
usually involve non-sequential samples [19-24]. In this
context, our objective was to analyze the main agents re-
lated to sepsis and the antimicrobial resistance profile of
those agents in a public university hospital.
Methods
Blood culture records that were requested from hospita-
lized patients in the Intensive Care Units (ICUs), Out-
patient Emergency Unit (OEU) and the wards of the
University Hospital during the course of one year were
analyzed retrospectively. The blood culture samples were
processed by the Microbiology Laboratory using the Bact/
Alert® (bioMérieux, USA) automated detection equip-
ment. Samples detected by the equipment were imme-
diately subcultured on blood agar, chocolate agar and
MacConkey agar plates for bacterial and fungal isolation,
and the bacterioscopy microscopic examination results
were reported immediately as preliminary results to the
doctor. The isolated colonies, 12 to 24 hours incubation
after incubation, were identified and evaluated for anti-
microbial susceptibility using Vitek® II (bioMérieux, USA)or by the disk diffusion test according to the standards of
the Clinical and Laboratory Standards Institute (CLSI),
which are updated annually.
The blood culture data were compared with informa-
tion obtained from the original processing worksheets
from the Laboratory of Microbiology and the Bact/Alert®
(bioMérieux, USA) database. Exact Fisher Test was used
to compare positive sample among medical specialties.
These data were analyzed using the SPSS (Statistical
Package for Social Sciences) v.21.0 (IBM Corp. Released
2012. IBM SPSS Statistics for Windows, Version 21.0.
Armonk, NY, USA). StatCalc – EpiInfo 7 (Atlanta, GA,
USA) calculated the power of sample. For the 4,793 en-
rolled, the positive sepsis diagnosis for 1,017 (21.21%)
has a confidence interval of 99.99%.
The inclusion criterion was a diagnosis of sepsis, ex-
cluding all other diagnoses such as bacteremia, fever and
repeated samples for the same patient within one month,
except in cases of agent change. In our casuistic was not
possible to characterize the septic shock and severe sep-
sis. In our study, the sepsis diagnosis was defined as the
presence (probable or documented) of infection together
with systemic manifestations of infection [1]. Cases with
potential contamination, when isolated from a single
sample, were excluded from the analysis. We considered
the following potential contaminating agents: Bacillus sp,
Bacillus cereus, Corynebacterium sp, Micrococcus sp, Pro-
pionibacterium sp, Streptococcus viridans and coagulase-
negative Staphylococcus (CNS). Regardless of the number
of positive samples for the same patient, only one strain
per patient was considered for the analysis of the anti-
microbial profile.
The study was authorized by the Ethical Committee
from State University of Campinas without the inclusion
of an informed consent.
Results
A total of 16,046 blood culture samples were collected
from 4,793 patients and processed by the Laboratory of
Microbiology. A total of 1,017 patients met the inclusion
criteria for the diagnosis of sepsis and included 2,309
samples (and an average of 2.27 samples collected per pa-
tient); 489 of these samples were positive (21% positive).
The medical specialties with the highest number of
patients diagnosed with sepsis were OEU with 440 pa-
tients (43.26%), adult ICU with 134 patients (13.18%)
and Neonatology with 104 patients (10.23%).
The average number of samples collected per patient
ranged from 1.8 to 2.94. The specialties with the highest
number of samples collected per patient were Neonatology
and the adult ICU, with approximately three samples per
patient. The specialties with the lowest average sample per
patient were Pediatrics and OEU, with approximately 1.9
samples per patient.
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nary unit with 50% positive samples, followed by the
adult ICU with 30.93%. The lowest percentage of posi-
tive samples occurred in Internal Medicine and OEU
(Table 1).
The 489 positive samples were isolated from 337 of
1,017 patients diagnosed with sepsis (33.13%), which left
680 patients with negative samples (66.87%). To analyze
the cases with the most evidence of sepsis, we excluded
71 patients who had only one positive sample for poten-
tial contaminants, leaving 266/1,017 patients (26.15%)
with potential pathogens. Of these 266 patients, 315 dif-
ferent agents were isolated in 418 positive samples (1.57
positive samples per patient). A total of 219 patients
(82.33%) had only a single agent, 45 patients (16.91%)
had two different agents and two patients (0.75%) had
three different agents (Tables 2 and 3).
In the Pediatric areas (Neonatology, Pediatric ward and
Pediatric ICU), 64 patients with positive samples were de-
tected, but 50% of these patients were positive in only a sin-
gle sample, which contained a potential Gram positive
contaminant. Of the remaining 32 patients with positive
samples, 19 had Gram positive isolates (Staphylococcus
aureus - nine patients, CNS - eight patients (more than
one positive sample of the same species) and Enterococcus -
two patients), eight had Gram negative isolates (Entero-
bacter spp - four patients, Enterobacter spp +Klebsiella
pneumoniae - one patient, Pseudomonas aeruginosa - one
patient, Escherichia coli - one patient and Haemophilus
influenzae - one patient), one patient had S. aureus and
Enterobacter spp, three patients had Candida albicans
and one patient had C. albicans and Proteus mirabilis.
The percentage of antimicrobial resistance in bacteria
isolated from 221 patients diagnosed with sepsis is
shown in Table 4.Table 1 Distribution by specialties, number of patients, samp
percentage of positive blood cultures of 2,309 samples collec
Medical
specialty
Patients Samples collected Positive sample
N % N % N %
OEU – UER 440 43.26 862 37.33 139 28.43
Internal medicine 113 11.11 296 12.82 35 7.16
Neonatology 104 10.23 306 13.25 82 16.77
ICU adult 134 13.18 362 15.68 112 22.90
ICU pediatric 34 3.34 73 3.16 16 3.27
Trauma surgery 31 3.05 67 2.90 18 3.68
Coronary unit 27 2.65 58 2.51 29 5.93
Pediatric ward 16 1.57 29 1.26 5 1.02
Other 118 11.60 256 11.09 53 10.84
Total 1,017 100.0 2,309 100.0 489 100.0
N = number of patients. *Statistical analysis performed by Exact Fisher Test. PositiveDiscussion
Among the patients diagnosed with sepsis, 2/3 were
from the OEU plus ICU adults and Neonatology, which
are the most critical areas of the hospital. The difference
in the average of two blood culture samples per patient
in OEU and three blood culture samples in the adult
ICU and Neonatology can be explained by the estab-
lished standard of using two samples per event per pa-
tient in acute cases and three samples per event per
patient for patients using a catheter and more seriously
ill patients.
The percentage of positive samples was higher in the
coronary unit (50%), probably because the sepsis diagno-
sis is less frequent, doctors are more confident about the
diagnosis and the blood cultures are used more judi-
ciously. The adult ICU had the next highest percentage
of positive samples (31%). The lowest percentages oc-
curred in Internal Medicine and OEU, with the latter be-
ing the area that accounted for the largest number of
samples collected and had a less systematized attendance
with overcrowding and overloaded conditions of service.
In general, the positivity rate of blood cultures can vary
greatly depending on the type and complexity of the in-
stitution and are, on average, 10 to 15%. Obviously, our
rate exceeding 20% can be explained by the selection of
cases with a diagnosis of sepsis, which generally does
not exceed 50%, even in cases of septic shock [10].
Some microorganisms are more often associated with
contamination (<5% chance of true bacteremia), inclu-
ding Corynebacterium spp., Micrococcus spp., Bacillus
spp. and Propionibacterium acnes, especially when iso-
lated in only one of two or more samples and when the
sample becomes positive over 72 hours of incubation
[12,15,17]. The S. viridans, Enterococcus spp. and CNS
organisms account, on average, for 38%, 78% and 15% ofles collected, positive samples, average per patient and





p-value* OR (95% CI)
1.96 16.13 <0.001 0.603 (0.481 – 0.753)
2.62 11.82 <0.001 0.461 (0.309 – 0.669)
2.94 26.8 0.0139 1.435 (1.075 – 1.903)
2.70 30.93 <0.001 1.865 (1.439 – 2.409)
2.15 21.92 0.969 1.046 (0.555 – 1.868)
2.16 26.87 0.315 1.381 (0.745 – 2.44)
2.15 50.00 <0.001 3.89 (2.219 – 6.821)
1.81 17.24 0.801 0.773 (0.261 – 1.937)
2.13 20.35 0.917 0.968 (0.689 – 1.343)
2.27 21.18
association is shown in bold.
Table 2 Distribution of the main pathogens detected in
blood cultures from 266 patients diagnosed with sepsis
Agent Number of patients Percentage
Coagulase negative Staphylococcus 50 15.87%
Escherichia coli 41 13.02%
Staphylococcus aureus 37 11.75%
Klebsiella pneumoniae 31 9.84%
Enterobacter sp 30 9.52%
Acinetobacter baumannii 29 9.21%
Pseudomonas aeruginosa 18 5.71%
Candida sp 16 5.08%
Enterococcus sp 14 4.44%
Proteus-Providencia-Morganella 12 3.81%
Serratia marcescens 8 2.54%
Streptococcus pneumoniae 8 2.54%
Streptococcus viridans 4 1.27%
Stenotrophomonas maltophilia 3 0.95%
Streptococcus bovis 3 0.95%
Other pathogens* 11 3.52%
Total 315 100.00%
*1 (0.32%) patient for the follow bacteria: Aeromonas caviae, Burkhloderia
cepacia, Citrobacter freundii, Corynebacterium sp, Cryptococcus neoformans,
Fusarium sp, Haemophilus influenza, Listeria monocytogenes, Pseudomonas
putida, Salmonella sp, Streptococcus pyogenes.
Table 3 Associations of bacteria isolated from 47 patients dia
Bacteria S. marcescens S. aureus A. baumannii SCN E.
E.coli 1 - - - -
E. cloacae - 2 3 1 -
K. pneumonia - 1 1 1 3
A. baumannii - - - 3 -
S. aureus - - - 2 -
E. faecalis - - 1* 4 -
P. aeruginosa - - - 3 1*
C. albicans - - - 1 -
C. tropicalis - - 1 1 -
Proteus spp - - - 2 -
S. pneumoniae - - 1 - -
B. cepacia - - 1 - -
Salmonella sp - - - 1 -
A. caviae - - - - -
P. putida - - - - -
Total 1 3 8 19 4
*Associated with S. maltophilia.
**Associated with E. aerogenes.
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according to different authors and study populations
[14-18]. Moreover, some microorganisms have a high
positive predictive value for true bacteremia (>90%),
even when they are isolated in only one sample. These
organisms include S. aureus, E. coli, Klebsiella spp and
other enterobacteria, Neisseria meningitidis, Streptococ-
cus pneumoniae, P. aeruginosa, Streptococcus pyogenes,
Streptococcus agalactiae, Listeria monocytogenes, Neis-
seria gonorrhoeae, H. influenzae, Brucella spp, Candida
spp and Cryptococcus spp [12].
We discarded 7% of patients from our analysis who
were considered to have blood cultures with potential
contaminants by the criteria described above. However,
this left 16% of the total cases with a CNS isolation,
which still was the most frequently isolated agent in this
series. This number of contaminants can be considered
reasonable considering that over 40% of all samples
taken were from OEU, where the collection conditions
are less favorable [18].
The distribution by agents refers to a general hospital,
including critical, immunosuppressed and transplant pa-
tients. Other factors can vary the distribution of agents,
such as a higher number of cases of surgical infections
(surgical hospitals) or community-acquired infections
(pneumonia, meningitis and infections of skin and soft
tissue), whereas the high number of infections by CNS
may be associated with the use of catheters, especially
those of long duration. The increasing isolation of non-
fermenting bacteria (P. aeruginosa and Acinetobactergnosed with sepsis
faecalis P. mirabilis E. cloacae E. coli E. aerogenes Total
- - - - 1
- - - - 6
1 1 1 1 10
- - - 2 5
1 - - 1 4
- - - - 5
* - - - 1 5
1 - - - 2
- - - - 2
- - - - 2
- - - - 1
- - - - 1
- - - - 1
- - 1 - 1
- 1 - - 1
3 2 2 5 47
Table 4 Percentage of antimicrobial resistance in bacteria isolated from 221 patients diagnosed with sepsis
Bacteria N AMI CPM CAZ PPT CIP IPM MER OXA ASB VAN ESBL+
E. coli 41 0 12 12 12 32 0 0 - 46 - 12
K. pneumoniae 31 3 70 70 70 56 0 0 - 77 - 71
E. cloacae 19 21 21 21 21 29 5 5 - 100 - -
E. aerogenes 11 82 77 77 77 66 0 0 - 100 - -
Other enterobacteria 21 5 5 5 5 5 0 0 - 43 - -
S. aureus 37 - - - - - - - 51 - 0 -
S coag neg 40 - - - - - - - 80 - 0 -
E. faecalis 12 - - - - - - - - - 0 -
E. faecium 2 - - - - - - - - - 50 -
A. baumannii 29 52 80 80 30 77 69 65 - 23 -
P. aeruginosa 18 28 29 17 12 35 17 17 - - -
N= number of patients, AMI = amikacin, CPM = cefepime, CAZ = ceftazidime, PPT = piperacillin-tazobactam, CIP = ciprofloxacin, IPM = imipenem, MER =meropenem,
OXA = oxacillin, ASB = ampicillin-sulbactam, VAN= vancomycin, ESBL = extended spectrum beta-lactamase.
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shows the presence of opportunistic agents associated
with nosocomial infection and invasive procedures. In
addition, opportunistic fungi of the genus Candida
accounted for 5% of sepsis cases; 60% (9/15) were C.
albicans, and 40% (6/15) were Candida tropicalis, which
indicates the importance of these species in hospital iso-
lates. The pediatric sampling is small and involves dif-
ferent sectors, but it shows a predominance of Gram
positive bacterial infections that probably come from the
community, whereas adult samples predominantly contain
Gram negative bacteria, indicating a probably greater role
of hospital infections.
Regarding the antimicrobial resistance results, we find that
51% of S. aureus are MRSA/ORSA (Methicillin-resistant
Staphylococcus aureus/oxacillin-resistant Staphylococcus
aureus), and we find an 80% methicillin/oxacillin resis-
tance rate for CNS, which suggests it is worthwhile intro-
ducing an alternative drug (vancomycin) until the results
of the antibiogram are available. The empirical therapy for
S. aureus should consider the prevalence of MRSA strains
in septic patients, which must be known on each unit or
ward. The potentially most useful drugs for the treatment
of major Gram negatives were carbapenems, with the ex-
ception of A. baumannii, which has better profile drugs
such as ampicillin sulbactam and piperacillin/tazobactam.
Enterobacteria showed, on average, 32.5% resistance to
beta-lactams, and when all Gram negatives were consid-
ered, this resistance rose to 40.5%. The findings were simi-
lar for ciprofloxacin, with 35.7% of Enterobacteriaceae and
42.3% of all Gram negatives being resistant. Therefore,
both third- and fourth-generation cefalosporins and quin-
olones are not recommended as the drug of choice for
empiric therapy. The rare profiles of resistance were a
vancomycin-resistant enterococci strain that, although en-
demic in our country, rarely causes sepsis and one case ofEnterobacter cloacae that is resistant to carbapenems. This
carbapenem-resistant E. cloacoe isolate was Hodge test
negative and PCR negative for Kpc, which suggests that
it does not produce a carbapenase. The mechanism of
resistance is probably through the production of an
AMPc-inducible beta-lactamase and the reduction of
porin channels [25].
The recent literature contains little data on bacterial re-
sistance in Brazilian hospitals or even in American or
European hospitals, with most publications linked to phar-
maceutical industry studies for the purpose of compa-
rative drug performance research; these studies include
other limitations, such as restrictions on etiologic agents,
the healthcare of centers involved, non-sequential samples
[19-24]. It is worth noting the difficulty of the empirical
use of antimicrobials, considering the high percentage of
strains of MRSA (51%) and about 40% of Gram-negative
resistance to beta-lactam and quinolones drugs, require-
ment for the rapid transmission of information from
microbiology laboratories such as the results of the Gram
stain, the antibiogram, determining the minimum inhibi-
tory concentration for rapid tests such as the Etest®, the
testing for resistance mechanisms such as AMPc, ESBL,
metallo-beta-lactamase, Kpc, VRE, MRSA, and fast and
confident automation resources for blood cultures and
bacterial identification are all critical for patient care, espe-
cially for cases of sepsis. The availability of experienced
and attentive microbiologists to analyze and make deci-
sions about unusual patterns of antimicrobial suscepti-
bility results and analysis of unreliable automation results
is essential, with special attention given to non-fermenting
bacteria. This study was restricted to the microbiology
ordering sheets analysis, the medical records were not
examined and the patients were not clinically assessed.
Therefore, it is not possible to properly classify their gra-
vity, risk factors, therapeutic choices and outcomes. There
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are no markers at present for the accurate and early detec-
tion of sepsis, which is diagnosed based on clinical signs
and laboratory data that are inadequately specific [9].
Cases of bacteremia may have been included, but the sam-
ple is representative of a continuous series of cases within
one year of microbiological data follow-up at a tertiary
general hospital. The accuracy of our routine diagnosis
based on bioMérieux VITEK II and current literature [26]
can be considered appropriate and in accordance with
international standards, although more sophisticated tech-
niques, such as mass spectrometry and amplification of
nucleic acids, have recently been introduced; however, the
impact of these new tests has yet to be assessed.
Conclusions
Eighty percent of the agents identified in blood cultures
from patients with sepsis belonged to a group of eight dif-
ferent agents. For empirical treatment, carbapenems and
vancomycin unfortunately still remain the best therapeutic
choice, except for A. baumannii and P. aeruginosa, for
which piperacillin/tazobactan is the best option.
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